Introduction
The Korean Society of Nephrology (KSN) has the largest continuous end-stage renal disease (ESRD) patient registry, established in 1985, in which all KSN members are participating voluntarily: the "Insan Prof. Min Memorial ESRD Patient Registry."
The objectives and importance of the patient registry and statistical evaluation of ESRD can be summarized as follows: (1) to estimate the numbers and distributions of target therapy patients by a dialysis specialist group (KSN); (2) to know the characteristics of ESRD and dialysis therapy, and its complications or results based on scientific evidence; and (3) to improve the quality of dialysis therapy, and provide information on socioeconomic health administration and the future health plan.
In 2013, because vascular access and dialysis quality became more important, KSN ESRD Committee has revised the online registry program. Newly included items were vascular access, dialysate components, calcium and phosphorous control, and rehabilitation status [1] .
Data collection method
The ESRD Registry Committee of KSN has collected data on dialysis centers and patients through an online registry program on the KSN Internet website (http://www.ksn.or. since 2007, whereas those with HD and KT have been increasing continuously; this is consistent with the trend observed in the United States [2] . The most common causes of ESRD in new patients were diabetic nephropathy, hypertensive nephrosclerosis, and chronic glomerulonephritis (50.6%, 18.5%, and 8.1%, respectively; Table 1 ). Among these three underlying diseases, the incidence of diabetic nephropathy increased rapidly during 1990-2000 (Fig. 1D) . The proportion of diabetic nephropathy in ESRD patients in Korea was one of the highest in the world, which was similar to some Asian countries and the United States [2] .
Renal replacement therapy modalities
Approximately 77% of new ESRD patients in 2012 started HD as their initial renal replacement therapy, whereas approximately 8% started PD. The prevalence rates of HD, PD, and KT were 69%, 11%, and 20%, respectively ( Fig. 2A) .
The numbers of HD centers and HD machines have also been increasing rapidly in Korea. At the end of 2012, Korea had 691 HD centers and 18,901 HD machines (Fig. 2B) . The ratio of machines per center was about 27, and that of patients per machine was 2.6 (Fig. 2C) . Approximately one-third of maintenance HD patients were admitted to university hospitals in the late 1990s, but currently, about 46% of HD patients are treated in private dialysis clinics (Fig. 2D ).
An analysis of the distribution of ESRD patients according to the zones in Korea showed that approximately 50% of HD patients and more than 50% of PD patients were located in the capital area (Fig. 2E) .
Dialysis patient demographics
The gender ratio of dialysis patients was 57.5% male and 42.5% female in HD therapy and 56.1% male and 43.9% female in PD therapy (Fig. 3A) .
The ABO blood type distribution of dialysis patients was type A, 34%; type B, 27%; type AB, 12%; type O, 27%, which was not different from the general population. Hepatitis B virus antigen was positive in 6% of dialysis patients and hepatitis C virus antibody in 4% (Fig. 3B) .
The mean age of dialysis patients was 59.2714.1 years. The age distribution of dialysis patients showed two peaks, one at the age of 50 years and the other at the age of 65 years (Fig. 3C) , indicating that at least two or more different disease groups are present among ESRD patients. The age distribution according to year since 1986 showed that the peak age has been shifting to older age and the current peak age is in the 60s (Fig. 3D) . The percentage of dialysis patients aged more than 65 years increased to up to 37.5% of overall dialysis patients in 2012.
The age distribution according to underlying diseases showed that the peak age of chronic glomerulonephritis was 53.7 years and that of diabetic nephropathy was 61.8 years (Fig. 3E) .
About 45% of HD patients and 44% of PD patients had been undergoing dialysis for more than 5 years; these percentages had increased from 30% and 14%, respectively, in 2001 (Fig. 3F) .
Approximately 53% of nondiabetic HD patients had been undergoing dialysis for more than 5 years, whereas only 35% of diabetic HD patients had been undergoing dialysis for the same period. Similarly, approximately 49% of nondiabetic PD patients and 34% of diabetic PD patients had been undergoing dialysis for more than 5 years (Fig. 3G) .
The mean body mass index was 22.173.4 kg/m 2 in HD patients and 24.273.7 kg/m 2 in PD patients; this showed a steady increase in both HD and PD groups. In HD patients, the mean body mass index was 22.673.5 kg/m 2 in diabetic patients and 21.773.2 kg/m 2 in nondiabetic patients (Fig. 3H) . The mean blood pressures were similar between HD and PD patients (99.7712.5 mmHg and 98.0712.8 mmHg, respectively; Fig. 3I ), but the pulse pressure was much higher in HD patients than in PD patients (64.2 mmHg vs. 52.2 mmHg, Fig. 3J ). Although the blood pressure of dialysis patients is decreasing, the pulse pressure of HD patients is increasing; this might be associated with the risk of cardiovascular morbidity.
Characteristics of HD, PD, and erythropoietin therapy HD frequency, dialyzer, and dialysate Most HD patients received dialysis three times per week (Fig. 4A) since 2000 (91.3% in 2012) . Hemodiafiltration therapy was performed in 11% of HD patients, but 53% of HD patients received dialysis with a dialyzer having a surface area of less than 1.5 m 2 (Fig. 4B) . Mostly bicarbonate and standard calcium (3.0 mEq/L) with glucose dialysate were used (Fig. 4C) .
Vascular access for HD
Of the HD patients, 79% had autologous arteriovenous fistula, of which 50% was in the left forearm, and 14% had graft fistula (Fig. 4D) .
PD catheter and dialysate dose
Of the PD patients, 48% had swan neck PD catheters and 23% had straight PD catheters. The PD catheter was inserted surgically in 62% of PD patients. The break-in period after catheter insertion was mostly 2-3 weeks, for both surgical and trochar insertions (Fig. 4E) . Automated PD therapy was applied to 24% of PD patients, and a PD dialysate volume of 10-12 L/day was used in 48% of PD patients (Fig. 4F ).
Anemia and erythropoietin therapy
In 2012, the mean hemoglobin level of HD patients was 10.471.1 g/dL and that of PD patients was 10.271.3 g/dL (Fig. 4G) . Although, theoretically, PD patients have a lower prevalence of anemia than HD patients, the recent use of erythropoietin therapy has increased hemoglobin levels in HD patients more than in PD patients. This therapeutic result is shown clearly in Figs. 4G and 4H: Of the HD patients, 46% were injected with 8,000 or more units of erythropoietin per week, whereas only 33% of PD patients were injected with this level of erythropoietin and 19% of PD patients were not injected with erythropoietin. The significant increase in the hemoglobin level of both dialysis patients in 2004 and 2005 was due to an increase in the reimbursement level of hemoglobin by the National Health Insurance.
Laboratory data and medications
The distribution of patient numbers according to calcium and phosphorous levels is shown in Fig. 4I ; the mean total calcium and phosphorous levels in HD patients were 8.8870.89 mg/dL and 5.14 71.64 mg/dL, respectively. Serum intact parathyroid hormone level of dialysis patients has been shown as a nature logarithmic scale distribution (Fig. 4J) . Calcium bicarbonate or acetate was used in 67% HD patients as a phosphate binder, and 24% of HD patients received vitamin D therapy (Fig. 4K) .
The mean serum albumin, creatinine, cholesterol, uric acid, and HbA1c levels in HD patients were 3.9 g/dL, 9.68 mg/dL, 144.0 mg/dL, 7.22 mg/dL, and 6.92%, respectively.
Dialysis adequacy
The mean urea reduction ratio was 67.9% in male and 74.1% in female HD patients (Fig. 4L ). This gender difference of dialysis adequacy resulted from the use of similar dialysis doses in men and women despite a body mass difference between the genders. The overall mean urea reduction ratio was 70.5 77.1%; which showed a steady increase.
The average nPCR and single-pool Kt/V were 0.9870.28 and 1.4970.29, respectively. Similar to the urea reduction ratio, both these values were higher in women than in men (Fig. 4M) . Single-pool Kt/V was higher in nondiabetic patients than in diabetic patients, presumably because of the quality of vascular access for dialysis (Fig. 4N) . The recent protein catabolic rate showed a slight decrease, presumably because of the increase in the proportion of elderly dialysis patients.
Distribution of patient numbers according to nPCR and singlepool Kt/V in case of HD patients and that according to nPNA and PD Kt/V in case of PD patients are shown in Figs. 4O and 4P .
Rehabilitation, morbidities, causes of death, and survival rates of dialysis patients
Rehabilitation
Of the PD patients, 33% had full-time jobs and 24% parttime jobs, but only 24% of HD patients had full-time jobs in 2012 (Fig. 5A) . This means that a higher rehabilitation rate was achieved in PD patients.
Comorbidity
The most common complications (51.2%) in HD patients were vascular diseases, which included hypertension, cerebrovascular accident, and other vascular diseases (Table 2) . Furthermore, 60.7% of PD patients had vascular diseases, and the infectious complication rate was higher in PD patients (8.5%) than in HD patients (5.0%).
Causes of death
The causes of death in dialysis patients in a descending order of frequency were cardiac causes, infection, and vascular disease. The cause of death was unknown or miscellaneous in onequarter of dialysis patients (Table 3 , Fig. 5B ). Some year-to-year variation was observed because of limitations in death reports.
Patient survival
The overall 1-and 5-year survival rates of dialysis patients were 95% and 72%, respectively (Fig. 5C ). These survival rates were higher than those observed in the United States and Japan [2, 3] , but the Korean survival rate was calculated only from the data of dialysis patients registered since 2001. The Korean ESRD Registry covers only about two-thirds of all dialysis patients in Korea because registry enrollment is voluntary.
The 5-year survival rate was higher in HD patients than in PD patients (72.6% vs. 68.3%; Fig. 5D ), and the 5-year survival rate was higher for chronic glomerulonephritis patients than for diabetic patients (86.4% vs. 61.4%; Fig. 5E ).
Kidney transplantation
In 2012, KT was performed in 1,783 cases, which included 768 deceased donors (Fig. 6) . The KT rate was 37 cases per 1,000 dialysis patients, which was below the world average [2] . However, the waiting number has been increasing sharply, and 12,463 surviving dialysis patients were enrolled in the Korean Network of Organ Sharing waiting list at the end of 2012.
Conclusion
The increasing proportion of elderly and diabetic patients in the Korean population has resulted in a rapid increase in the number of ESRD patients, which reached 1,353 PMP at the end of 2012. A high proportion of diabetic ESRD patients (50.6%) and a decrease in the proportion of PD patients were observed recently. Among ESRD patients, the proportion of HD has increased to 69%, PD decreased to 11%, and KT has remained at 20%. The adequacies of dialysis and anemia therapy have been improving steadily in Korea.
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